TY - JOUR
T1 - γδβ-Thalassemia due to a de novo mutation deleting the 5' β-globin gene activation-region hypersensitive sites
AU - Driscoll, M. C.
AU - Dobkin, C. S.
AU - Alter, B. P.
PY - 1989
Y1 - 1989
N2 - γδβ-Thalassemia is a rare disorder of hemoglobin biosynthesis, characterized molecularly by partial or complete deletions of the β-globin gene complex of 100 kilobases (kb) or greater. Common to all mutants described has been the deletion of the most-5' sequences of the β-globin complex. We have used the techniques of pulsed field gel electrophoresis and polymerase chain reaction to study a patient with a clinical γδβ-thalassemia phenotype. This subject developed a de novo deletion on a maternally inherited β-globin gene chromosome involving ~30 kb of sequences 5' to the ε gene; the deletion extends from -9.5 kb to -39 kb 5' of ε and includes three of the four DNase I hypersensitive sites (at -10.9 kb, -14.7 kb, and -18 kb 5' of ε). The remaining sequences of the β-globin complex, including the DNase I hypersensitive sites at -6.1 kb and all structural genes in cis to the deletion are physically intact, but presumably nonfunctional, as evidenced by the presence of a β(s)-globin gene that is not expressed as a sickle hemoglobin. Deletion of DNase I hypersensitive sites on a previously functional β-globin gene complex confirms the significance of these sites in regulating globin gene expression.
AB - γδβ-Thalassemia is a rare disorder of hemoglobin biosynthesis, characterized molecularly by partial or complete deletions of the β-globin gene complex of 100 kilobases (kb) or greater. Common to all mutants described has been the deletion of the most-5' sequences of the β-globin complex. We have used the techniques of pulsed field gel electrophoresis and polymerase chain reaction to study a patient with a clinical γδβ-thalassemia phenotype. This subject developed a de novo deletion on a maternally inherited β-globin gene chromosome involving ~30 kb of sequences 5' to the ε gene; the deletion extends from -9.5 kb to -39 kb 5' of ε and includes three of the four DNase I hypersensitive sites (at -10.9 kb, -14.7 kb, and -18 kb 5' of ε). The remaining sequences of the β-globin complex, including the DNase I hypersensitive sites at -6.1 kb and all structural genes in cis to the deletion are physically intact, but presumably nonfunctional, as evidenced by the presence of a β(s)-globin gene that is not expressed as a sickle hemoglobin. Deletion of DNase I hypersensitive sites on a previously functional β-globin gene complex confirms the significance of these sites in regulating globin gene expression.
UR - http://www.scopus.com/inward/record.url?scp=0012953756&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0012953756&partnerID=8YFLogxK
U2 - 10.1073/pnas.86.19.7470
DO - 10.1073/pnas.86.19.7470
M3 - Article
C2 - 2798417
AN - SCOPUS:0012953756
SN - 0027-8424
VL - 86
SP - 7470
EP - 7474
JO - Proceedings of the National Academy of Sciences of the United States of America
JF - Proceedings of the National Academy of Sciences of the United States of America
IS - 19
ER -